How the Duration Period of Erythropoietin Treatment Influences the Oxidative Status of Hemodialysis Patients

Background: End-stage renal disease is a state of enhanced oxidative stress (OS) and hemodialysis (HD) and renal anemia further augment this disbalance. Anemia correction with erythropoietin (EPO) may improve oxidative status. However, there is no evidence of time dependent effects of EPO therapy on...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimitrijevic, Zorica M., Cvetkovic, Tatjana P., Djordjevic, Vidojko M., Pavlovic, Dusica D., Stefanovic, Nikola Z., Stojanovic, Ivana R., Paunovic, Goran J., Velickovic-Radovanovic, Radmila M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491441/
https://www.ncbi.nlm.nih.gov/pubmed/23136545
http://dx.doi.org/10.7150/ijms.4910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491441/
https://www.ncbi.nlm.nih.gov/pubmed/23136545
http://dx.doi.org/10.7150/ijms.4910

Ejemplares similares